Skip to main contentSkip to navigation
Sirius Investors
Atrion Corporation

Atrion Corporation

ATRI
NASDAQHealthcare

Atrion Corporation (ATRI) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Atrion Corporation's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2023
P/E Ratio
0.03
Strong
WeakModerateStrong
P/B Ratio
0.00
Strong
WeakModerateStrong
Earnings Yield
29.10%
Strong
WeakModerateStrong

Profitability Health

2023
Return on Equity
7.99%
Weak
WeakModerateStrong
Operating Margin
13.33%
Moderate
WeakModerateStrong
Net Profit Margin
11.46%
Moderate
WeakModerateStrong

Growth Indicators

2023
Revenue Growth
-7.73%
Weak
WeakModerateStrong
Net Income Growth
-44.55%
Weak
WeakModerateStrong
EPS Growth
-43.75%
Weak
WeakModerateStrong

Efficiency & Liquidity

2023
Current Ratio
9.09
Strong
WeakModerateStrong
Quick Ratio
2.57
Strong
WeakModerateStrong
Asset Turnover
0.65x
Moderate
WeakModerateStrong
Inventory Turnover
1.30x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2023
Free Cash Flow Yield
-3.47%
Weak
WeakModerateStrong
EV / Free Cash Flow
1.15x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.09x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.991
Strong
WeakModerateStrong
Return on Invested Capital
7.89%
Weak
WeakModerateStrong
Cash Conversion Cycle
307.95 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ATRI.

View Financial Statements